Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with Chronic Myeloid Leukemia

Altered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate

Ellin Berman, Robert G. Maki, Martin Fleisher et al. · New England Journal of Medicine · 2006 · 317 citations · Full text

Medicine, Endocrinology, Oncology +17

Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study

Martin Champagne, Renaud Capdeville, Mark Krailo et al. · Blood · 2004 · 238 citations

Medicine, Hematology, Oncology +11

Long-term imatinib therapy promotes bone formation in CML patients

Stephen Fitter, Andrea L. Dewar, P. Kostakis et al. · Blood · 2007 · 155 citations

Medicine, Oncology, Bone Metabolism +9

Imatinib Promotes Osteoblast Differentiation by Inhibiting PDGFR Signaling and Inhibits Osteoclastogenesis by Both Direct and Stromal Cell-Dependent Mechanisms

Susannah O’Sullivan, Dorit Naot, Karen E. Callon et al. · Journal of Bone and Mineral Research · 2007 · 126 citations · Full text

Medicine, Oncology, Pharmacology +17

Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation

Frédéric Millot, Joëlle Guilhot, Brigitte Nelken et al. · Leukemia · 2005 · 96 citations

Medicine, Oncology, Pharmacotherapy +6